Valuation: Sawai Group Holdings Co., Ltd.

Capitalization 256B 1.63B 1.4B 1.27B 1.21B 2.21B 149B 2.32B 14.96B 5.99B 71.67B 6.1B 5.97B P/E ratio 2026 *
16.9x
P/E ratio 2027 * 12.8x
Enterprise value 306B 1.94B 1.68B 1.51B 1.45B 2.65B 179B 2.77B 17.88B 7.16B 85.64B 7.29B 7.14B EV / Sales 2026 *
1.5x
EV / Sales 2027 * 1.41x
Free-Float
-
Yield 2026 *
2.52%
Yield 2027 * 2.59%
1 day+0.27%
1 week-4.37%
Current month-4.37%
1 month-6.05%
3 months+3.79%
6 months+11.34%
Current year-5.91%
1 week 2,163.5
Extreme 2163.5
2,339.5
1 month 2,163.5
Extreme 2163.5
2,425
Current year 2,163.5
Extreme 2163.5
2,447
1 year 1,650
Extreme 1650
2,447
3 years 1,085
Extreme 1085
2,447
5 years 1,085
Extreme 1085
2,447
10 years 1,085
Extreme 1085
2,773.33
Manager TitleAgeSince
Chief Executive Officer 69 01/04/2021
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 68 01/06/2023
Director TitleAgeSince
Chairman 69 01/04/2021
Director/Board Member 65 01/06/2025
Director/Board Member 74 01/04/2021
Change 5d. change 1-year change 3-years change Capi.($)
+0.27%-4.37%+7.69%+77.32% 1.63B
+0.72%-5.86%+13.89%+218.81% 885B
+0.32%-3.23%+44.22%+56.01% 579B
-0.96%-0.85%+7.38%+50.47% 407B
-2.93%-7.03%+11.14%+27.55% 350B
-1.25%-5.55%+22.14%+55.83% 302B
-1.85%-6.70%+20.11%+33.64% 301B
-0.24%-6.49%+22.33%+4.06% 286B
+0.53%-4.80%+13.75%+61.56% 199B
-0.83%-3.37%+22.59%+79.29% 179B
Average -0.62%-4.66%+18.52%+66.45% 349.04B
Weighted average by Cap. -0.47%-4.59%+20.27%+89.09%

Financials

2026 *2027 *
Net sales 204B 1.29B 1.11B 1.01B 965M 1.76B 119B 1.84B 11.89B 4.77B 56.97B 4.85B 4.75B 217B 1.38B 1.19B 1.07B 1.03B 1.88B 127B 1.97B 12.7B 5.09B 60.81B 5.18B 5.07B
Net income 14.81B 93.97M 81.02M 73.14M 70.18M 128M 8.64B 134M 865M 346M 4.14B 353M 345M 20.19B 128M 110M 99.7M 95.66M 174M 11.77B 183M 1.18B 472M 5.65B 481M 471M
Net Debt 49.96B 317M 273M 247M 237M 432M 29.13B 452M 2.92B 1.17B 13.97B 1.19B 1.16B 51.21B 325M 280M 253M 243M 442M 29.86B 463M 2.99B 1.2B 14.32B 1.22B 1.19B
Logo Sawai Group Holdings Co., Ltd.
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
Employees
3,310
Date Price Change Volume
06/03/26 2,219.50 ¥ +0.27% 414,500
05/03/26 2,213.50 ¥ +1.03% 472,900
04/03/26 2,191.00 ¥ -3.33% 425,400
03/03/26 2,266.50 ¥ -1.84% 309,900
02/03/26 2,309.00 ¥ -0.52% 360,300
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
2,219.50JPY
Average target price
2,677.78JPY
Spread / Average Target
+20.65%

Quarterly revenue - Rate of surprise